Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Nov 1;114(13):1702-1713.
doi: 10.1093/cvr/cvy174.

Diabetes and aortic aneurysm: current state of the art

Affiliations
Review

Diabetes and aortic aneurysm: current state of the art

Juliette Raffort et al. Cardiovasc Res. .

Abstract

Aortic aneurysm is a life-threatening disease due to the risk of aortic rupture. The only curative treatment available relies on surgical approaches; drug-based therapies are lacking, highlighting an unmet need for clinical practice. Abdominal aortic aneurysm (AAA) is frequently associated with atherosclerosis and cardiovascular risk factors including male sex, age, smoking, hypertension, and dyslipidaemia. Thoracic aortic aneurysm (TAA) is more often linked to genetic disorders of the extracellular matrix and the contractile apparatus but also share similar cardiovascular risk factors. Intriguingly, a large body of evidence points to an inverse association between diabetes and both AAA and TAA. A better understanding of the mechanisms underlying the negative association between diabetes and aortic aneurysm could help the development of innovative diagnostic and therapeutic approaches to tackle the disease. Here, we summarize current knowledge on the relationship between glycaemic parameters, diabetes, and the development of aortic aneurysm. Cellular and molecular pathways that underlie the protective effect of diabetes itself and its treatment are reviewed and discussed, along with their potential implications for clinical translation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Hypothesized protective effects of diabetes mellitus in AAA and TAA. The main mechanisms that underlie the protective effect of diabetes in the pathogenesis of aortic aneurysm are mediated through effects on aortic mural neoangiogenesis, intraluminal thrombus formation, inflammation, glycation, extracellular matrix remodelling, and vascular smooth muscle homeostasis. Even though AAA and TAA share common pathophysiological mechanisms, they are characterized by distinct features. The main pathways underlying the protective effect of diabetes mellitus may differ between AAA and TAA.
Figure 2
Figure 2
Hypothesized protective effects of antidiabetic treatments in AAA. Antidiabetic treatments may contribute to the negative association observed between diabetes and AAA through protective effects on inflammation, neoangiogenesis, extracellular matrix remodelling, and oxidative stress.

References

    1. Golledge J, Muller J, Daugherty A, Norman P.. Abdominal aortic aneurysm: pathogenesis and implications for management. Arterioscler Thromb Vasc Biol 2006;26:2605–2613. - PubMed
    1. Guo DC, Papke CL, He R, Milewicz DM.. Pathogenesis of thoracic and abdominal aortic aneurysms. Ann N Y Acad Sci 2006;1085:339–352. - PubMed
    1. Nordon IM, Hinchliffe RJ, Loftus IM, Thompson MM.. Pathophysiology and epidemiology of abdominal aortic aneurysms. Nat Rev Cardiol 2011;8:92–102. - PubMed
    1. Raffort J, Lareyre F, Clement M, Hassen-Khodja R, Chinetti G, Mallat Z.. Monocytes and macrophages in abdominal aortic aneurysm. Nat Rev Cardiol 2017;14:457–471. - PubMed
    1. Davis FM, Rateri DL, Daugherty A.. Mechanisms of aortic aneurysm formation: translating preclinical studies into clinical therapies. Heart 2014;100:1498–1505. - PubMed

Publication types

MeSH terms